Decision letter for "Single‐dose euglycemic clamp study in two cohorts to compare exposure of SAR341402 (insulin aspart) Mix 70/30 to US ‐ and EU‐Approved versions of insulin aspart Mix 70/30 and SAR341402 rapid‐acting solution in subjects with type 1 diabetes"
Single-Dose Euglycemic Clamp Study Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and US- and EU-Approved Versions of Insulin Aspart in Subjects with Type 1 Diabetes
2020 ◽
Vol 22
(4)
◽
pp. 278-284
◽
2020 ◽
2020 ◽
Keyword(s):
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2019 ◽
Vol 21
(4)
◽
pp. 1066-1070
◽